UAB Sanobiotec
JAR Code: 305534922
ActiveFinancial Reports
| 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|
| Revenue | 2 740 890 | 3 108 432 | 4 378 340 | 5 141 439 | |
| Profit Before Tax | — | 594 219 | 155 770 | 114 647 | |
| Net Profit | 433 121 | 594 219 | 118 633 | 76 462 | |
| Profit margin | 15.8% | 19.1% | 2.7% | 1.5% | |
| Equity | 453 135 | 1 047 357 | 1 019 037 | 1 095 500 | |
| Liabilities | 722 567 | 941 075 | 1 239 469 | 1 248 252 | |
| Total Assets | 1 175 422 | 1 988 432 | 2 258 506 | 2 343 752 |
Financial Reports
2024
Balance Sheet
Total Assets2 343 752 €
Long-term Assets375 307 €
Short-term Assets1 968 445 €
Equity1 095 500 €
Liabilities1 248 252 €
Profit & Loss Statement
Revenue5 141 439 €
Profit Before Tax114 647 €
Net Profit76 462 €
2023
Balance Sheet
Total Assets2 258 506 €
Long-term Assets311 954 €
Short-term Assets1 946 552 €
Equity1 019 037 €
Liabilities1 239 469 €
Profit & Loss Statement
Revenue4 378 340 €
Profit Before Tax155 770 €
Net Profit118 633 €
2022
Balance Sheet
Total Assets1 988 432 €
Long-term Assets402 612 €
Short-term Assets1 585 820 €
Equity1 047 357 €
Liabilities941 075 €
Profit & Loss Statement
Revenue3 108 432 €
Profit Before Tax594 219 €
Net Profit594 219 €
2021
Balance Sheet
Total Assets1 175 422 €
Long-term Assets221 728 €
Short-term Assets953 694 €
Equity453 135 €
Liabilities722 567 €
Profit & Loss Statement
Revenue2 740 890 €
Profit Before Tax—
Net Profit433 121 €
2020(2020-04-06 – 2020-12-31)9 mėn.
Balance Sheet
Total Assets129 213 €
Long-term Assets2 362 €
Short-term Assets126 851 €
Equity20 013 €
Liabilities109 200 €
Profit & Loss Statement
Revenue230 109 €
Profit Before Tax—
Net Profit17 513 €
Source: Registrų centras